Zimmer Biomet Holdings to Present at Raymond James & Associates’ 41st Annual Institutional Investors Conference

On February 28, 2020 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, reported that it will participate in Raymond James & Associates’ 41st Annual Institutional Investors Conference at the JW Marriott Grande Lakes in Orlando (Press release, Zimmer Holdings, FEB 28, 2020, View Source;associates-41st-annual-institutional-investors-conference-301013383.html [SID1234554997]). Suky Upadhyay, Executive Vice President and Chief Financial Officer and Keri Mattox, Senior Vice President, Investor Relations and Chief Communications Officer, will present for the Company on Monday, March 2, 2020, at 9:50 a.m. Eastern Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation can be accessed via Zimmer Biomet’s Investor Relations website at https://investor.zimmerbiomet.com.